Cabot Co. (NYSE:CBT) Holdings Lowered by T. Rowe Price Investment Management Inc.

T. Rowe Price Investment Management Inc. decreased its stake in Cabot Co. (NYSE:CBT - Free Report) by 39.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 551,940 shares of the specialty chemicals company's stock after selling 364,956 shares during the period. T. Rowe Price Investment Management Inc. owned 1.02% of Cabot worth $50,398,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. R Squared Ltd acquired a new position in shares of Cabot during the fourth quarter valued at $26,000. EverSource Wealth Advisors LLC boosted its stake in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after purchasing an additional 219 shares during the period. GAMMA Investing LLC grew its position in Cabot by 10.7% in the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after purchasing an additional 130 shares during the last quarter. Manchester Capital Management LLC increased its stake in shares of Cabot by 1,685.1% in the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after purchasing an additional 1,584 shares during the period. Finally, KBC Group NV raised its holdings in shares of Cabot by 43.1% during the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock valued at $187,000 after buying an additional 616 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CBT shares. Mizuho decreased their price objective on Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. decreased their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research note on Friday, February 21st. UBS Group cut their price objective on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. Finally, StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research report on Thursday, April 17th.

Cabot Price Performance

Shares of CBT traded down $1.20 during midday trading on Thursday, reaching $77.34. The stock had a trading volume of 200,908 shares, compared to its average volume of 392,605. The firm's 50 day moving average price is $81.48 and its 200-day moving average price is $93.14. Cabot Co. has a 52 week low of $73.63 and a 52 week high of $117.46. The company has a market capitalization of $4.19 billion, a P/E ratio of 10.27, a P/E/G ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. On average, analysts forecast that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.